The DOI matches its Crossref record.
Fistula First Breakthrough Initiative: Targeting Catheter Last in Fistula First
Abstract
An arteriovenous fistula (AVF) is the optimal vascular access for hemodialysis (HD), because it is associated with prolonged survival, fewer infections, lower hospitalization rates, and reduced costs. The AVF First breakthrough initiative (FFBI) has made dramatic progress, effectively promoting the increase in the national AVF prevalence since the program’s inception from 32% in May 2003 to nearly 60% in 2011. Central venous catheter (CVC) use has stabilized and recently decreased slightly for prevalent patients (treated more than 90 days), while CVC usage in the first 90 days remains unacceptably high at nearly 80%. This high prevalence of CVC utilization suggests important specific improvement goals for FFBI. In addition to the current 66% AVF goal, the initiative should include specific CVC usage target(s), based on the KDOQI goal of less than 10% in patients undergoing HD for more than 90 days, and a substantially improved initial target from the current CVC proportion. These specific CVC targets would be disseminated through the ESRD networks to individual dialysis facilities, further emphasizing CVC avoidance in the transition from advanced CKD to chronic kidney failure, while continuing to decrease CVC by prompt conversion of CVC‐based hemodialysis patients to permanent vascular access, utilizing an AVF whenever feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Robinson, B. M., Akizawa, T., Jager, K. J., Kerr, P. G., Saran, R., & Pisoni, R. L. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30448-2 · Cited by 415
Norris, A. H., Shrestha, N. K., Allison, G. M., Keller, S. C., Bhavan, K. P., Zurlo, J. J., Hersh, A. L., Gorski, L. A., Bosso, J. A., Rathore, M. H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy745 · Cited by 372
Pisoni, R. L., Zepel, L., Port, F. K., & Robinson, B. M. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.12.014 · Cited by 329
The molecular mechanisms of hemodialysis vascular access failure
Brahmbhatt, A., Remuzzi, A., Franzoni, M., & Misra, S. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.019 · Cited by 259
Metadata
- Authors
- Vassalotti, J. A., Jennings, W. C., Beathard, G. A., Neumann, M., Caponi, S., Fox, C. H., Spergel, L. M., & the Fistula First Breakthrough Initiative Community Education Committee
- Venue
- Seminars in Dialysis
- Publisher
- Wiley
- Published
- 2012-04-04
- Volume
- 25
- Issue
- 3
- Pages
- 303-310
- ISSN
- 0894-0959 (ISSN-L)
- 1525-139X
- OpenAlex
- W2140819650
- Cited by
- 201
- References
- 0
- FWCI
- 24.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fistula First Breakthrough Initiative: Targeting Catheter Last in Fistula First. https://app.cochat.ai/papers/10.1111/j.1525-139x.2012.01069.x
- The paper
- Vassalotti, J. A., Jennings, W. C., Beathard, G. A., Neumann, M., Caponi, S., Fox, C. H., Spergel, L. M., & the Fistula First Breakthrough Initiative Community Education Committee. (2012). Fistula First Breakthrough Initiative: Targeting Catheter Last in Fistula First. Seminars in Dialysis. https://doi.org/10.1111/j.1525-139x.2012.01069.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.